Andrea Schiefer

Meckenheimer Allee 168
Bonn, NW 53115, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Activity of Corallopyronin A Against ESKAPEE Pathogens: Potential and Translational Implications.

Activity of Corallopyronin A Against ESKAPEE Pathogens: Potential and Translational Implications.

Journal: Antibiotics (Basel, Switzerland)

Published: June 12, 2026

Constrained RNA polymerase mutational pathways distinguish corallopyronin A resistance from rifampicin resistance in staphylococci.

Constrained RNA polymerase mutational pathways distinguish corallopyronin A resistance from rifampicin resistance in staphylococci.

Journal: Scientific reports

Published: April 07, 2026

Sustained Drug Exposure Drives Efficacy in Mice: PK/PD Analysis of Corallopyronin A against Wolbachia using Physiologically Based Absorption Modeling.

Sustained Drug Exposure Drives Efficacy in Mice: PK/PD Analysis of Corallopyronin A against Wolbachia using Physiologically Based Absorption Modeling.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 12, 2026

Breaking Down Barriers: CorA Effectively Targets Staphylococcal Biofilms in Vitro and in Vivo.

Breaking Down Barriers: CorA Effectively Targets Staphylococcal Biofilms in Vitro and in Vivo.

Journal: ChemMedChem

Published: November 20, 2025

Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections.

Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections.

Journal: Infection

Published: June 20, 2025

No resistance development against corallopyronin A in Wolbachia in C6/36 cell culture.

No resistance development against corallopyronin A in Wolbachia in C6/36 cell culture.

Journal: International journal of antimicrobial agents

Published: August 06, 2024

Erratum for Balthazar et al., "A laboratory-based predictive pathway for the development of Neisseria gonorrhoeae high-level resistance to corallopyronin A, an inhibitor of bacterial RNA polymerase".

Erratum for Balthazar et al., "A laboratory-based predictive pathway for the development of Neisseria gonorrhoeae high-level resistance to corallopyronin A, an inhibitor of bacterial RNA polymerase".

Journal: Microbiology spectrum

Published: July 01, 2024

A laboratory-based predictive pathway for the development of Neisseria gonorrhoeae high-level resistance to corallopyronin A, an inhibitor of bacterial RNA polymerase.

A laboratory-based predictive pathway for the development of Neisseria gonorrhoeae high-level resistance to corallopyronin A, an inhibitor of bacterial RNA polymerase.

Journal: Microbiology spectrum

Published: April 22, 2024

In vitro extracellular replication of Wolbachia endobacteria.

In vitro extracellular replication of Wolbachia endobacteria.

Journal: Frontiers in microbiology

Published: March 22, 2024

The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular Chlamydia and Wolbachia and Break the Persistence Phenotype in Chlamydia.

The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular Chlamydia and Wolbachia and Break the Persistence Phenotype in Chlamydia.

Journal: Antibiotics (Basel, Switzerland)

Published: March 04, 2024

Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations.

Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations.

Journal: Pharmaceutics

Published: February 05, 2024

Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus.

Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus.

Journal: Pharmaceutics

Published: November 21, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026